Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Denise Grathwohl"'
Autor:
Khalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei, Matthias Reinscheid, Sebastian Giese, Kevin Ciminski, Georg Kochs, Martin Schwemmle, Julia Lang-Meli, Michelle Maas, Natascha Roehlen, Vivien Karl, Anne Graeser, Oezlem Sogukpinar, Ivana von Metzler, Denise Grathwohl, Leo Rasche, Holger Hebart, Miriam Kull, Florian Emmerich, Cornelius Florian Waller, Justus Duyster, Monika Engelhardt, Tanja Nicole Hartmann, Bertram Bengsch, Tobias Boettler, Christoph Neumann-Haefelin, Maike Hofmann, Robert Thimme, Hendrik Luxenburger
Publikováno v:
Vaccines, Vol 12, Iss 11, p 1249 (2024)
Background: Multiple myeloma (MM) patients are at high risk of severe infections including COVID-19 due to an immune dysregulation affecting both innate and adaptive immune responses. However, our understanding of the immune responses to infection an
Externí odkaz:
https://doaj.org/article/139b7f29dd3841dcaa4f950d263f58df
Autor:
Chris David Lauruschkat, Ihsan Muchsin, Alice Rein, Florian Erhard, Denise Grathwohl, Lars Dölken, Carolin Köchel, Christine Susanne Falk, Hermann Einsele, Sebastian Wurster, Götz Ulrich Grigoleit, Sabrina Kraus
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionHuman cytomegalovirus (HCMV) causes significant morbidity and mortality in allogeneic stem cell transplant (alloSCT) recipients. Recently, antiviral letermovir prophylaxis during the first 100 days after alloSCT replaced PCR-guided preemp
Externí odkaz:
https://doaj.org/article/2fc7ef57f2ff4e4eab17aff5d14e1a6f
Autor:
Xiang Zhou, Maximilian J. Steinhardt, Denise Grathwohl, Katharina Meckel, Katharina Nickel, Hans‐Benno Leicht, Franziska Krummenast, Hermann Einsele, Leo Rasche, Klaus M. Kortüm
Publikováno v:
Cancer Medicine, Vol 9, Iss 16, Pp 5819-5826 (2020)
Abstract Background Even in the era of novel immunotherapies for multiple myeloma (MM), treatment of late‐stage relapsed/refractory (RR) patients remains challenging. The aim of our study was to analyze the efficacy and safety of the five‐drug co
Externí odkaz:
https://doaj.org/article/de8c2d8802274012a1aac441c04130c1
Autor:
Tao Bai, Xue Zhu, Xiang Zhou, Denise Grathwohl, Pengshuo Yang, Yuguo Zha, Yu Jin, Hui Chong, Qingyang Yu, Nora Isberner, Dongke Wang, Lei Zhang, K. Martin Kortüm, Jun Song, Leo Rasche, Hermann Einsele, Kang Ning, Xiaohua Hou
Publikováno v:
Frontiers in Artificial Intelligence, Vol 4 (2021)
Cohort-independent robust mortality prediction model in patients with COVID-19 infection is not yet established. To build up a reliable, interpretable mortality prediction model with strong foresight, we have performed an international, bi-institutio
Externí odkaz:
https://doaj.org/article/65e3a3566af4436e8f3c514571424962
Autor:
Xiang Zhou, Hui Chong, Xiaohua Hou, Nora Isberner, Yuguo Zha, Dongke Wang, Hermann Einsele, Pengshuo Yang, Yu Jin, Kang Ning, Tao Bai, Jun Song, Denise Grathwohl, Leo Rasche, Xue Zhu, Qingyang Yu, Lei Zhang, K. Martin Kortüm
Publikováno v:
Frontiers in Artificial Intelligence, Vol 4 (2021)
Frontiers in Artificial Intelligence
Frontiers in Artificial Intelligence
Cohort-independent robust mortality prediction model in patients with COVID-19 infection is not yet established. To build up a reliable, interpretable mortality prediction model with strong foresight, we have performed an international, bi-institutio
Autor:
K. Martin Kortüm, Lei Zhang, Xiang Zhou, Leo Rasche, Xiaohua Hou, Jun Song, Denise Grathwohl, Yu Jin, Pengshuo Yang, Xue Zhu, Tao Bai, Nora Isberner, Qingyang Yu, Dongke Wang, Hermann Einsele, Kang Ning, Hui Chong
Publikováno v:
SSRN Electronic Journal.
Background: Cohort-independent robust mortality prediction model in patients with COVID-19 infection is not yet established, while this mortality prediction model could help for early triaging, optimizing the medical resource and adjust the treatment
Autor:
Denise Grathwohl, Johannes Düll, Leo Rasche, Katharina Nickel, Maximilian Johannes Steinhardt, Martin Kortüm, Sophia Danhof, Xiang Zhou, Katharina Meckel, Andreas Rosenwald, Hans‐Benno Leicht, Franziska Krummenast, Hermann Einsele
We herein report the case of a 73‐year‐old male patient who was diagnosed with leukemic non‐nodal MCL. This patient had received six cycles of bendamustine, which resulted in a transient remission, and a second‐line therapy with ibrutinib, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a58f1f8dee43546caa379d7fd0a6034
https://opus.bibliothek.uni-wuerzburg.de/files/21551/EJH_EJH13382.pdf
https://opus.bibliothek.uni-wuerzburg.de/files/21551/EJH_EJH13382.pdf
Autor:
Hans‐Benno Leicht, Max Steinhardt, Katharina Nickel, Franziska Krummenast, Katharina Meckel, Xiang Zhou, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Denise Grathwohl
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e285